IRIS
MAIDA, Ivana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.230
AS - Asia 5.314
EU - Europa 5.216
SA - Sud America 2.911
AF - Africa 216
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 13
Totale 21.917
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.054
BR - Brasile 2.570
SG - Singapore 2.135
IT - Italia 2.026
CN - Cina 1.568
UA - Ucraina 944
FR - Francia 613
HK - Hong Kong 513
DE - Germania 474
VN - Vietnam 397
SE - Svezia 271
FI - Finlandia 194
GB - Regno Unito 141
AR - Argentina 121
IE - Irlanda 99
NL - Olanda 98
BD - Bangladesh 84
RU - Federazione Russa 78
TR - Turchia 78
IN - India 68
CA - Canada 64
IQ - Iraq 64
MX - Messico 62
ZA - Sudafrica 61
EC - Ecuador 56
PK - Pakistan 45
PL - Polonia 45
CZ - Repubblica Ceca 41
JP - Giappone 40
MA - Marocco 40
ES - Italia 39
UZ - Uzbekistan 36
KR - Corea 34
CO - Colombia 32
VE - Venezuela 32
ID - Indonesia 30
PY - Paraguay 29
AZ - Azerbaigian 27
BE - Belgio 27
AT - Austria 24
KE - Kenya 23
AE - Emirati Arabi Uniti 22
CL - Cile 22
TN - Tunisia 22
UY - Uruguay 20
IR - Iran 19
PE - Perù 19
DZ - Algeria 18
AU - Australia 17
KZ - Kazakistan 17
EG - Egitto 16
CH - Svizzera 13
IL - Israele 13
JO - Giordania 13
LB - Libano 12
NP - Nepal 12
PA - Panama 12
SA - Arabia Saudita 12
EU - Europa 11
LT - Lituania 11
PH - Filippine 10
PS - Palestinian Territory 10
RS - Serbia 10
AL - Albania 9
SN - Senegal 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
HU - Ungheria 8
CR - Costa Rica 7
GA - Gabon 7
OM - Oman 7
BG - Bulgaria 6
BH - Bahrain 6
BY - Bielorussia 6
GE - Georgia 6
JM - Giamaica 6
KG - Kirghizistan 6
KW - Kuwait 6
NG - Nigeria 6
QA - Qatar 6
NI - Nicaragua 5
BA - Bosnia-Erzegovina 4
ET - Etiopia 4
HN - Honduras 4
MD - Moldavia 4
MK - Macedonia 4
RO - Romania 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
GR - Grecia 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AM - Armenia 2
BN - Brunei Darussalam 2
CY - Cipro 2
GT - Guatemala 2
HR - Croazia 2
ML - Mali 2
MY - Malesia 2
Totale 21.888
Salva come PNG Salva come JPEG
Città #
Dallas 2.605
Singapore 1.157
Chandler 913
San Jose 699
Jacksonville 557
Hong Kong 505
Ashburn 364
Princeton 332
Beijing 322
Nanjing 254
Dearborn 187
São Paulo 179
Rome 176
Lauterbourg 166
Ho Chi Minh City 153
New York 150
Milan 137
Wilmington 124
Shanghai 111
Boardman 108
Los Angeles 104
Nanchang 103
Sassari 101
Dublin 98
Ann Arbor 97
Hanoi 92
Rio de Janeiro 89
Santa Clara 79
Shenyang 75
Belo Horizonte 67
Tianjin 64
Naples 63
Munich 59
Florence 50
Woodbridge 50
Hebei 48
Changsha 46
Brasília 44
Helsinki 44
Porto Alegre 41
Tokyo 38
Andover 37
Brno 37
Jiaxing 37
Nuremberg 36
Campinas 35
Orem 35
Jinan 34
Tashkent 34
Turin 33
Seoul 32
Hangzhou 31
Frankfurt am Main 30
Goiânia 30
San Francisco 30
Bari 29
Buffalo 29
Curitiba 29
Guarulhos 29
Warsaw 29
Ningbo 28
Palermo 28
Toronto 28
Brussels 27
Johannesburg 26
Baghdad 25
Council Bluffs 25
Ribeirão Preto 25
Zhengzhou 25
Baku 24
Norwalk 24
Bologna 23
Dhaka 23
Montreal 23
Chicago 22
Kunming 22
Salvador 22
Sorocaba 22
Atlanta 20
Fortaleza 20
Montevideo 20
Nairobi 20
Turku 20
Brooklyn 19
Verona 19
Guangzhou 18
Haiphong 18
London 18
Buenos Aires 17
Campo Grande 17
Juiz de Fora 17
São José dos Campos 17
Asunción 16
Betim 16
Caxias do Sul 16
Columbus 16
Joinville 16
Recife 16
Santo André 16
São Bernardo do Campo 16
Totale 12.097
Salva come PNG Salva come JPEG
Nome #
CASE REPORT: MIOCARDITE ACUTA DA CITOMEGALOVIRUS IN GIOVANE PAZIENTE IMMUNOCOMPETENTE 1.926
Accertamento diagnostico di meningoencefalite da Listeria monocytogenes mediante PCR in soggetti immunocompetenti 288
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 278
Analisi dell'attività dei C.I.O. in ambito regionale e proposta di un modello organizzativo - funzionale 231
Analisi del case-mix ospedaliero. Il controllo dei ricoveri outlier 217
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 212
Strategie di sorveglianza attiva e networking per il controllo delle infezioni da L. monocytogenes 205
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 201
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 188
Andamento della parotite epidemica nell’Azienda USL n.1 di Sassari e considerazioni sulle strategie vaccinali 183
Aspetti epidemiologici di infezioni gastroenteriche in paesi in via di sviluppo 181
Aspetti epidemiologici sulla colonizzazione da Streptococcus agalactiae nelle donne in gravidanza. 180
Approccio molecolare nello studio di un episodio infettivo ospedaliero da Pseudomonas aeruginosa 178
alpha-and gamma-tocophetol modulate the apoptotic signaling induced by oxidized low-density lipoprotein in human coronaric smooth muscle cells 177
Antibiotic resistant H-pylori are extremely common in Sardinia. 176
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 174
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 171
Approccio molecolare nella diagnosi della tubercolosi umana 168
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 166
Associazione sierologia tra HIV e Trichomonas vaginalis nella popolazione femminile del Nord-Sardegna. 161
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 159
Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C 156
Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. 153
Andamento delle infezioni nosocomiali nel complesso chirurgico Università- Azienda USL n. 1- Sassari. 143
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 143
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 141
Genotypic characterization of clarithromycin-resistant Helicobacter pylori strains 140
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 137
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 137
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 137
Comparison of 2D Shear Wave Elastography and Transient Elastography in Non-Invasive Evaluation of Liver Fibrosis in Hepatitis C Virus-Related Chronic Liver Disease 136
Utilizzo della metodologia bayesiana per lo studio della variazione geografica del rischio in epidemiologia. 136
Clonal relationships among Salmonella enteritidis phage type 3 outbreak isolates traced by DNA fingerprinting 136
QuantiFERON TB Gold: a new method for latent tuberculosis infection 135
Valutazione della qualità delle schede di dimissione ospedaliera 135
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 135
PREVENTION OF TRAVEL ASSOCIATED INFECTION DUE TO LEGIONELLA: MICROBIOLOGIC ANALYSIS IN LINERS AND CRUISE SHIPS 134
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 134
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution 133
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 128
Neurocognitive performance and cardiovascular risk in a cohort of HIV-infected patients 127
Inquinamento ambientale nelle sale operatorie. Nota II: condizioni microclimatiche e microbiologiche 127
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 123
Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes 122
Occurrence of infections during combination treatment with interferons and ribavirin for chronic hepatitis C: Role of neutropenia and of interferon pegylation 122
Listeria monocytogenes meningoencephalitis: molecular methods for diagnosis and for monitoring the response to chemotherapy 121
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcome 121
Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus 121
Pulmonary Involvement in Recurrent Respiratory Papillomatosis: A Systematic Review 120
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 120
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 120
Monitoraggio di metalli pesanti nelle acque costiere della Sardegna settentrionale mediante utilizzo di indicatori biologici 119
Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study. 118
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 118
Rapid detection and identification of Mycobacterium tuberculosis by Real Time PCR and Bactec 960 MIGT 118
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 118
Joint replacement for avascular necrosis in people living with HIV 118
HIV related aneurisms 117
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 116
Epidemiology of Salmonellosis in Sardinia, Italy: 1995-2001 115
Characterization of resistance profiles in HCV 2-3-4 DAA-naive and DAA-experienced infected patients in Italy 115
OPERA: use of pegylated interferon plus ribavirin for treating hepatitis C/HIV co-infection in interferon-naive patients. 115
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 115
Genetic determinants in critical domains of NS5A are associated with genotype 1b HCV-induced hepatocellular carcinoma 114
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 113
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 113
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir. 113
Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience 112
Hepatitis C virus-RNAclearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin 112
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 110
Epidemiologia e prevenzione delle infezioni da Micobatteri su base molecolare 109
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes 109
Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients 108
Database per il monitoraggio del rischio professionale negli operatori sanitari 108
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 107
Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies 107
Surveillance of Poliomyelitis in Italy: immunity status of population against polio and environmental circulation of Poliovirus. General illustration of the results 107
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 106
Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir 106
Predictors of Virological Response to Atazanavir in Protease Inhibitor-Experienced Patients 106
Modulation by α- and γ-tochopherol and oxidized low density lipoprotein in human coronaric smooth muscle cells 106
Characteristics and Prospects for Hepatitis C Therapy of an HIV-HCV Coinfected Population Followed at a Reference HIV Center 104
Serum homocysteine levels are increased in women with gestational diabetes mellitus 104
Failure of Hepatitis C Therapy in HIV-Coinfected Drug Users Is Not Due to a Shift in Hepatitis C Virus Genotype 103
Specific Genetic Determinants in NS5A and Core Regions Correlate with Genotype 1b HCV-Induced Hepatocellular Carcinoma: Implications for Viral Markers of Disease Progression 103
Severe liver disease associated with prolonged exposure to antiretroviral drugs 103
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 102
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies 102
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection. 102
Evalutaion and comparison of molecular techniques for epidemiological typing of M. tuberculosis 102
Very late HCV relapse following triple therapy for hepatitis C. 101
Hepatitis C Viremia in HIV/HCV-Coinfected Patients: Lower Levels in Presence of Chronic Hepatitis B 101
Triple-nucleoside regimens versus efavirenz 101
Simplification From Protease Inhibitors to Once- or Twice-Daily Raltegravir: The ODIS Trial 101
Database per il monitoraggio del rischio professionale negli operatori sanitari 101
The changing face of the HIV epidemic in Northern Sardinia: increased diagnoses among pregnant women 100
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation 99
Severe portal hypertension in HIV patients with no primary liver disease: prevalence, histology and potential etiology 99
Quick diagnostic approach for HIV/STDs among migrants: results from a monocentric Italian cohort 98
Does counselling increase sustained benefit of HAART among prison inmates after release to the community? 98
Totale 15.085
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.464
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021423 0 0 0 0 0 0 0 0 0 230 138 55
2021/2022965 152 27 24 46 18 19 45 67 77 32 110 348
2022/20231.962 199 101 39 314 190 334 21 222 331 25 108 78
2023/2024930 105 62 32 41 193 96 27 52 16 57 97 152
2024/20255.792 113 161 376 136 197 193 360 1.074 1.964 763 314 141
2025/20268.010 345 1.982 1.231 1.222 735 451 1.168 236 332 308 0 0
Totale 22.246